FDA releases gene therapy guidance documents

FDA Wednesday released six draft guidance documents on gene therapy: three advising companies on how to use the technology to treat certain diseases, two about manufacturing and one on the design of long-term follow-up studies.

The disease-specific draft guidance documents provide advice about developing gene therapies for hemophilia, retinal disorders and rare diseases. ...